Newer antihistaminic agents

Philip S. Norman

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Two new antihistamines with properties different from those of currently available drugs are nearing licensure. Named terfenidine and astemizole, they are almost exclusively H1-antagonists, lacking anticholinergic and sympathetic activity. They fail to penetrate the central nervous system and lack sedative effects. They are long-acting and require less frequent doses. Thus they allow sustained antihistaminic action without the usual side effects.

Original languageEnglish (US)
Pages (from-to)366-368
Number of pages3
JournalThe Journal of allergy and clinical immunology
Issue number2 PART 2
StatePublished - Aug 1985

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Newer antihistaminic agents'. Together they form a unique fingerprint.

Cite this